Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models
- PMID: 19745811
- PMCID: PMC2771093
- DOI: 10.1038/emboj.2009.257
Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models
Abstract
The relation of alpha-synuclein (alphaS) aggregation to Parkinson's disease (PD) has long been recognized, but the mechanism of toxicity, the pathogenic species and its molecular properties are yet to be identified. To obtain insight into the function different aggregated alphaS species have in neurotoxicity in vivo, we generated alphaS variants by a structure-based rational design. Biophysical analysis revealed that the alphaS mutants have a reduced fibrillization propensity, but form increased amounts of soluble oligomers. To assess their biological response in vivo, we studied the effects of the biophysically defined pre-fibrillar alphaS mutants after expression in tissue culture cells, in mammalian neurons and in PD model organisms, such as Caenorhabditis elegans and Drosophila melanogaster. The results show a striking correlation between alphaS aggregates with impaired beta-structure, neuronal toxicity and behavioural defects, and they establish a tight link between the biophysical properties of multimeric alphaS species and their in vivo function.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures








Similar articles
-
Pre-fibrillar α-synuclein mutants cause Parkinson's disease-like non-motor symptoms in Drosophila.PLoS One. 2011;6(9):e24701. doi: 10.1371/journal.pone.0024701. Epub 2011 Sep 8. PLoS One. 2011. PMID: 21931820 Free PMC article.
-
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.Neurobiol Dis. 2018 Mar;111:36-47. doi: 10.1016/j.nbd.2017.12.004. Epub 2017 Dec 12. Neurobiol Dis. 2018. PMID: 29246724 Free PMC article.
-
Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.Biochemistry. 2010 Feb 9;49(5):862-71. doi: 10.1021/bi901723p. Biochemistry. 2010. PMID: 20041693 Free PMC article.
-
A glimpse into the structural properties of α-synuclein oligomers.Biofactors. 2024 May-Jun;50(3):439-449. doi: 10.1002/biof.2021. Epub 2023 Dec 8. Biofactors. 2024. PMID: 38063360 Review.
-
Interactions of α-synuclein oligomers with lipid membranes.Biochim Biophys Acta Biomembr. 2021 Apr 1;1863(4):183536. doi: 10.1016/j.bbamem.2020.183536. Epub 2020 Dec 26. Biochim Biophys Acta Biomembr. 2021. PMID: 33373595 Review.
Cited by
-
Curcumin modulates α-synuclein aggregation and toxicity.ACS Chem Neurosci. 2013 Mar 20;4(3):393-407. doi: 10.1021/cn3001203. Epub 2012 Dec 17. ACS Chem Neurosci. 2013. PMID: 23509976 Free PMC article.
-
Wild-Type α-Synuclein Structure and Aggregation: A Comprehensive Coarse-Grained and All-Atom Molecular Dynamics Study.J Chem Inf Model. 2024 Aug 12;64(15):6115-6131. doi: 10.1021/acs.jcim.4c00965. Epub 2024 Jul 24. J Chem Inf Model. 2024. PMID: 39046235 Free PMC article.
-
Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity.Acta Neuropathol Commun. 2015 Jan 31;3:7. doi: 10.1186/s40478-015-0185-3. Acta Neuropathol Commun. 2015. PMID: 25637461 Free PMC article.
-
Effects of Mutations and Post-Translational Modifications on α-Synuclein In Vitro Aggregation.J Mol Biol. 2022 Dec 15;434(23):167859. doi: 10.1016/j.jmb.2022.167859. Epub 2022 Oct 19. J Mol Biol. 2022. PMID: 36270580 Free PMC article. Review.
-
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders.Front Neurosci. 2021 Mar 29;15:656921. doi: 10.3389/fnins.2021.656921. eCollection 2021. Front Neurosci. 2021. PMID: 33854417 Free PMC article. Review.
References
-
- Ader C, Schneider R, Seidel K, Etzkorn M, Becker S, Baldus M (2009) Structural rearrangements of membrane proteins probed by water-edited solid-state NMR spectroscopy. J Am Chem Soc 131: 170–176 - PubMed
-
- Chen L, Feany MB (2005) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8: 657–663 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases